Cargando…
Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
Autor principal: | Reiffel, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192146/ https://www.ncbi.nlm.nih.gov/pubmed/32369043 http://dx.doi.org/10.19102/icrm.2020.110404 |
Ejemplares similares
-
Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient
por: Reiffel, James A.
Publicado: (2019) -
Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018) -
Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not
por: Reiffel, James A.
Publicado: (2019) -
Adverse Events with Amiodarone—Will the List Ever End?
por: Reiffel, James A.
Publicado: (2018) -
“Ranolaziodarone”—A Synergism You Should Not Miss
por: Reiffel, James A.
Publicado: (2021)